Bank of Montreal’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Bank of Montreal's REGN Position: Q2 2026 in Review
Bank of Montreal increased its Regeneron Pharmaceuticals (REGN) stake by 21% in Q2 2026, buying an estimated $12.1M and bringing the position to 103,247 shares worth $64.4M. The position accounts for 0.02% of the portfolio, ranked #521.
Bank of Montreal first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $253M in Q4 2023. 1,339 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Bank of Montreal held 103,247 shares of Regeneron Pharmaceuticals worth $64.4M as of Q2 2026.
- Bank of Montreal bought 17,723 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $12.1M.
- Regeneron Pharmaceuticals made up 0.02% of Bank of Montreal's portfolio in Q2 2026, its #521 holding.
- Bank of Montreal first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Bank of Montreal's Regeneron Pharmaceuticals position peaked at $253M in Q4 2023.
- 1,339 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.